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Objective: The prevalence of osteoarthritis (OA) varies between joints. Cartilage in eight different joints
was evaluated to elucidate the disparate susceptibilities between joints to post-traumatic OA (PTOA) and
provide evidence for joint-speciﬁc clinical treatments. The hypothesis was that cartilage in different
joints would have varying cell death and anabolic gene expression proﬁles after injury.
Methods: Adult equine cartilage explants were harvested from shoulder (SH), elbow (EL), carpal (CA),
metacarpophalangeal (MC), patellofemoral (FP), tarsal (TA), metatarsophalangeal (MT), and proximal
interphalangeal (PP) joints, and injured by loading with 30 MPa within 1 s. Fractional dissipated energy,
cell density, cell death, and gene expression were quantiﬁed.
Results: PP had the highest fractional dissipated energy (94%, 95% conﬁdence interval [CI] 88 to 101%).
Cell density was highest in the superﬁcial zone in all samples, with MC and MT having the highest peak
density. Injured samples had signiﬁcantly increased cell death (13.5%, 95% CI 9.1 to 17.9%) than non-
injured samples (6.8%, 95% CI 2.5 to 11.1%, P ¼ 0.016); however, cell death after injury was not signiﬁ-
cantly different between joints. Gene expression was signiﬁcantly different between joints. CD-RAP
expression in normal cartilage was lowest in FP (Cp ¼ 21, 95% CI 80 to 122). After injury, the change in
CD-RAP expression increased and was highest in FP (147% relative increase after injury, 95% CI 64 to 213).
Conclusion: Different joints have different baseline characteristics, including cell density and gene
expression, and responses to injury, including energy dissipation and gene expression. These unique
characteristics may explain differences in OA prevalence and suggest differences in susceptibility to
PTOA.
Clinical Relevance: Understanding differences in the response to injury and potential susceptibility to OA
can lead to the development of preventative or treatment strategies.
Key terms: Gene expression, cartilage injury, chondrocyte, multiphoton microscopy, cartilage biome-
chanical properties, PTOA.
What is known about the subject: The prevalence of OA is variable among joints; however, most labo-
ratory studies are performed on a single joint e most commonly the knee, and extrapolated to other
joints such as the ankle or shoulder. A small number of studies have compared knee and ankle cartilage
and reported differences in mechanical properties and gene expression.
What this study adds to existing knowledge: There are differences in baseline cell density and gene
expression, and differences in response to injury, including gene expression and cell death. This suggests
that there are inherent differences leading to varying susceptibilities in OA prevalence among joints.
Joint-speciﬁc treatments may improve OA therapies.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.L.A. Fortier, C3-181 Veterinary Medical Center, Cornell University, Ithaca, NY 14853, USA. Tel: 1-607-253-3102; Fax: 1-
ternational. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) affects the worldwide population1, with an
estimated 5.6 million Americans suffering from post-traumatic OA
(PTOA) of lower-extremities, creating a $3 billion annual cost to
society2. Research in OA is often performed by examining a single
joint such as the knee, and the ﬁndings might be extrapolated to
other unrelated joints. With this approach, there is an underlying
assumption that different joints respond similarly to varying
stimuli and share similar susceptibility to OA. Yet, the prevalence
and type of OA is not the same between joints. In 500 patients with
combinations of unilateral, bilateral, and multiple-joint OA, the
distribution of 847 OA-affected joints has been reported as 41.2%
knees, 30.0% hands, 19.0% hips, 4.4% ankles, 3.2% shoulders, 1.6%
elbows, and 0.6% wrists3. Different types of OA have different
prevalences in each joint. PTOA which is associated with prior
injury, accounts for 12.5%4 of OA in the knee but 54%4e78%5 in the
ankle. Conversely, spontaneously-occurring OA not associated with
any pathologies, accounts for 82%4 of OA in the knee but only
9%5e14.6%4 in the ankle. The hand can be subcategorized to further
demonstrate variability of OA between joints with similar motion.
The prevalence of OA in the proximal interphalangeal and meta-
carpophalangeal joints in 1300 women is 16.5% and 6.8%, respec-
tively6. Within a single joint, such as the knee, there is varying
prevalence of OA between regions. In a 3 year study, 24% of patients
had radiographic signs of OA in the patellofemoral joint, 4% in the
tibiofemoral joint, and 41% in both regions of the knee7. With these
differences in prevalence of OA, understanding the differences of
healthy cartilage and the resilience to injury between different
joints can help facilitate the development of OA therapeutics,
particularly joint-speciﬁc treatments.
Differences in susceptibility to OA between joints may be
inﬂuenced by variations in response to stimuli or in biochemical or
biomechanical properties of cartilage between joints. These dif-
ferences have been shown in a small subset of joints. Knee and
ankle cartilage respond differently to stimuli. Cytokine stimulation
with interleukin-1b decreases the synthesis of glycosaminoglycans
(GAGs) in the knee to a greater extent than in the ankle, where
3.5 pg/ml and 35 pg/ml, respectively, are needed to elicit the same
50% reduction in GAG synthesis8. Mechanical stimulation by cyclic
hydrostatic pressure (0.33 Hz,16 kPamax gauge pressure) increases
aggrecan expression in knee but not ankle chondrocytes9. Knee and
ankle cartilages have different biochemical and mechanical prop-
erties. Dynamic stiffness and GAG content are higher in the ankle
than the knee10. The reported differences between this small subset
of joints suggest that differences might occur more widely among
joints than previously thought.
Cellular distribution and cartilage thickness vary between joints
and correlate with biomechanical properties. These characteristics
may elucidate differences in susceptibility to OA. Chondrocyte
density inversely correlates with thickness of cartilage: thinner
cartilage has a higher cell density (as many as 330,000 cells mm3),
and thicker cartilage has a lower cell density (up to
14,000 cells mm3)11. Thicker tissue has both a smaller proportion
of superﬁcial zone cartilage12 and a lower superﬁcial zone cell
density11. The superﬁcial layer is important for compressive and
shear biomechanical properties12,13, with superﬁcial zone thick-
ness having a positive correlation with isotropic indentation
modulus12. While cartilage thickness has been shown to be unre-
lated to normal standing stress14, it can be altered by injury15. This
suggests that cartilage thickness and density may contribute to but
not deﬁne susceptibility to OA. Cellular distribution as a function of
depth may help further characterize differences between joints
and be a factor in resilience to cartilage damage and development
of OA.Current literature suggests variability in a small subset of major
joints exists, both with respect to baseline cellular density, syn-
thesis activities, and response to injury. While injury has been
established to cause cell death in cartilage16,17, the difference be-
tween multiple joints in response to injury has not been studied.
Understanding these differences will lead to better understanding
the unique progression of PTOA between joints and the potential
for development of joint-speciﬁc OA treatments.
In the present study, the aim was to answer the following
questions by evaluating cartilage in eight major equine joints:
(1) Are there variations between joints in normal cartilage
characteristics, as deﬁned by cell viability, distribution, and
density, and gene expression?
(2) Are some joints more resilient to compressive loading and
the resulting cell death and catabolic gene expression than other
joints?
By answering these questions, this paper presents evidence
supporting the hypothesis that cartilage in different joints is
inherently different. Consequently, susceptibility to PTOA is
different. Our ﬁndings of in vitro cell death and gene expression
reveal that the pathogenesis of PTOA is likely joint-speciﬁc.
Methods
Tissue collection and injury model
Six millimeter diameter cartilage biopsy punches were har-
vested aseptically fromyoung adult horses (ages 2.5e4 years, n¼ 4)
immediately after euthanasia with approval from the Institutional
Animal Care and Use Committee. Articular cartilage was harvested
from the high impact region of caput humeri of the shoulder joint
(SH), condylus lateralis radii of the elbow joint (EL), proximal surface
of os carpale III of the carpal joint (CA)18, condylus lateralis metacarpi
III of the metacarpophalangeal joint (MC)19,20, condylus lateralis
phalanx proximalis III of the proximal interphalangeal joint (PP),
condylus lateralis femoris/trochlea ossis femoris of the patellofemoral
joint (FP)21, the distal surface of os tarsi centrale of the tarsal joint
(TA)21, and condylus lateralis metatarsi III of the meta-
tarsophalangeal joint (MT)19e21. Cartilage was grossly evaluated
and scored using the International Cartilage Repair Society Clinical
Cartilage Injury Evaluation System e 200022,23. Explants were
equally divided into control and injury groups and then equally
distributed for either imaging or gene expression analysis (Fig. 1).
Cartilage explants used for imaging were marked with a standard
laboratory permanent marker at harvest to ensure that all images
were acquired in the same anterior-posterior orientation. Explants
were placed in phenol red-free MEMwith 25 mM Hepes, 100 IU/ml
penicillin, and 100 mg/ml streptomycin.
For compressive injury, explants were brieﬂy removed from
media and placed in a custom chamber containing the described
media. The chamber was then placed under 2.25 mm-diameter
indenter on an EnduraTEC ELF3200 mechanical test frame
(EnduraTec, Minnetonka, MN). The articular surface was injured
with a single compression of 117.4 N (95% conﬁdence interval [CI]
117.6 to 117.2 N), to achieve a stress of 30 MPa24,25 under load
control within 1 s. Samples were subjected to a mean peak stress
rate of 130 MPa s1 (95% CI 125 to 136), with no signiﬁcant dif-
ferences peak stress rates found between samples (P ¼ 0.731).
Temporal load and displacement data were recorded, and force-
edisplacement curves (Fig. 1) were generated for each sample by
plotting the raw data. The load at which the sample yielded was
found by generating the second derivative of the forceedisplace-
ment curve, with respect to displacement by numerical
Fig. 1. Schematic of methods. Biopsy punches (diameter ¼ 6 mm) were harvested (n ¼ 4 animals), divided equally into control and injured groups, and distributed to image or gene
expression analysis.
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point was deﬁned as the minima on the second derivative curve.
Fractional dissipated energy was calculated from the force-
edisplacement curve using the following equation
E ¼
Ptm
t¼0 Ftð xt  xt1Þ 





Ptf
tm Ft ð xt  xt1Þ





Ptm
t¼0 Ftðxt  xt1Þ
where E represents the fractional dissipated energy, F represents
the force, x represents displacement, and t represents time where
tm is the time at maximum displacement and tf is the end of the
impact. This quantity measures the energy dissipated within the
system normalized to the maximum energy applied to the system.
It represents the fraction of the energy applied during loading that
is dissipated.
After injury, explants for imaging were immediately replaced
into media and incubated for 60 min at 37C at 5% CO2 to allow any
immediate biological changes and cell death to occur. Gene
expression explants were transferred to Ham's F-12 medium,
containing 25 mM Hepes, 2 mM L-glutamine, 50 mg/ml ascorbic
acid, 30 mg/ml a-ketoglutaric acid, and 10% FBS and incubated for
48 h at 37C at 5% CO2 to capture changes in expression of a diverse
proﬁle of genes.Multiphoton data acquisition and analysis
After the 60 min incubation, explants were cut in cross-section
and placed in 1 mM sodium ﬂuorescein (AK-FLUOR 25%, Akorn, Inc.,
Lake Forest, IL) in PBS for multiphoton microscopy (MPM) imag-
ing25. Images were collected using a Tsunami titanium:sapphire
laser (Newport Corp., Irvine, CA) with 780 nmwavelength at 100 fs
pulses and 80 MHz. Emission spectra were collected through a
670 nm long-pass dichroic and photomultiplier tubes using ﬁlters
of 380e490 nm to collect second harmonic generation, and
510e650 nm to collect ﬂuorescein emission.
To quantify cell density, images from normal controls were
converted to binary images using Fiji with Sauvola local
threshold26. Binary images were processed with custom code inMATLAB to identify and quantify all chondrocytes as a function of
depth, using 50 mm binning. The relationship of cell density and
depth for each sample was evaluated by ﬁtting an exponential
decay curve to the data points to characterize how the density of
cells changed from the articular surface to the deep zone. The
exponential decay curve's decay length (“b”, where b ¼ x in
y ¼ Aex/b) was quantiﬁed for each individual sample to utilize a
numerical characteristic to describe the change in cell density with
depth. A smaller value of decay rate length indicates a relatively
dense region of cells at the surface and a signiﬁcantly less dense
region of cells in the middle and deep zones. A larger value of decay
rate length indicates amore uniform distribution of cells among the
surface, middle, and deep zones. This decay rate length was
compared between joints.
To quantify the density of cells in the superﬁcial zone, cells from
the superﬁcial zone were identiﬁed in the above described images
by selecting those cellular proﬁles demonstrating an orientation
within [-16, 16] compared to the articular surface. A histogram
distribution of cellular proﬁles with 50 mm binning was calculated
to determine the maximum density and depth at which maximal
density occurred. Cell death was manually quantiﬁed in normal
controls and injured samples using 50 mm binning.
Gene expression analysis
After 48 h, explants for gene expression were rinsed in PBS,
transferred to RLT lysis buffer (Qiagen, Germantown, MD), snap
frozen in liquid nitrogen, and stored at 80C until processing. The
explant and buffer were pulverized in liquid nitrogen using a
mortar and pestle. Then total RNA was isolated using the RNeasy
Fibrous Tissues mini kit (Qiagen). Species-speciﬁc intron-spanning
equine primers were used to amplify cartilage genes collagen type
2a1 (COL2A1), aggrecan (AGG), cartilage-derived retinoic acid-
sensitive protein (CD-RAP), heat shock protein 90 (HSP90) and in-
ﬂammatory genes serum amyloid A (SAA), matrix metal-
loproteinase 1 (MMP-1), and MMP-13. Primers are listed in Table I.
Quantitative real-time RT-PCR (qPCR) was performed using the
LightCycler® Fast Start DNA Master SYBR Green I and LightCycler®
Real-Time PCR System (Roche Diagnostics, Indianapolis, IN). Results
were calculated using the efﬁciency corrected calculation method
Table I
Primers used for real time quantitative RT-PCR. Primers were designed by the au-
thors unless otherwise indicated27
Primer name Primer sequence (50 / 30) Primer source
18S F GAT ACC GCA GCT AGG AAT DQ222453.1
18S R ATC TGT CAA TCC TGT CCG
Aggrecan F CTT AGA GGA CAG AAA GCG AC Trumble et al.27
Aggrecan R ACT TTG GGC GGA AGA AGG
CD-RAP F ATG CCC AAG CTG GCT GA EF679787
CD-RAP R CTT CGA TTT TGC CAG GTT TC
Collagen type 2a1 F TCT GCA GAA TGG GCA GAG GTA TA NM_031163
Collagen type 2a1 R GAT AAT GTC ATC GCA GAG GAC ATT C
HSP 90 F GGA TCT GGT CAT CCT GCT CTA C NM_001163955.1
HSP 90 R ACG TGT CGT CAT CTC CTT CA
MMP-1 F CAG TGC CTT CAG AAA CAC GA AF148882.1
MMP-1 R GCT TCC CAG TCA CTT TCA GC
MMP-13 F GCT GCC TAT GAG CAT CCT TC NM_001081804.1
MMP-13 R ACC TCC AGA CCT GGT TTC CT
Serum amyloid A F CCT GGG CTG CTA AAG TCA TC AF240364.1
Serum amyloid A R AGG CCA TGA GGT CTG AAG TG
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Normalized relative ratio ¼ ECT ðtarget calibratorÞCTt
ðtarget sampleÞ=ECT ðreference calibratorÞCT ðreference sampleÞr 28. All
genes were normalized to 18S. Expression is reported as normal-
ized Cp ratios with higher normalized ratio values indicating higher
gene expression.
Statistical analysis
To determine the differences between joints in cartilage
compressive loading at yield point, fractional dissipated energy,
chondrocyte density decay rate length, superﬁcial zone chon-
drocyte peak density and density z-depth location, cell death in
control and after injury, a mixed model ANOVAwhile treating joint
as ﬁxed factor and the horse ID as random factor with an LSD post-
hoc analysis was used. Assumptions of normality of residuals wereTable II
The fractional dissipated energy was signiﬁcantly different between shoulder (SH), elbo
(FP), tarsal (TA), and metatarsal (MT) joints (P ¼ 0.003). The maximum displacement as
conﬁdence interval (CI95). An LSD post-hoc test was used to determine differences betw
having 0.001  P < 0.05, and dark gray boxes having P < 0.001
PP MT TA FP
Max disp (CI95) 0.84 (0.76e0.91) 0.44 (0.33e0.56) 0.34 (0.29e0.38) 1.12 (0.77e
% (CI95) 94 (88,101) 80 (74,87) 83 (77,89) 87 (80,94)
PP 0.001 0.007 0.090
MT 0.457 0.102
TA 0.322
FP
MC
CA
EL
Table III
Chondrocyte density decay rate length with goodness of ﬁt as R2. An exponential decay cu
a shorter exponential decay of cell density than a larger value. Cartilage in the should
patellofemoral (FP), tarsal (TA), and metatarsal (MT) joints were evaluated. Decay rate
CI ¼ conﬁdence interval
SH EL CA
Decay length (mm) 573 281 273
95% CI: lower 242 122 48
95% CI: upper 1390 440 497
R2 0.56 0.75 0.60
95% CI: lower 0.15 0.57 0.29
95% CI: upper 1.28 0.92 0.91veriﬁed. All statistical analyses were performed with SPSS version
22 (IBM Corporation, Armonk, NY), and signiﬁcance was evaluated
at P < 0.05.Results
Cartilage injury yield and fractional dissipative energy
To compare the mechanical response to compressive loading,
peak load at the yield point and fractional dissipative energy were
determined. The peak load at which tissue yielded was not signif-
icantly different between joints (P ¼ 0.185). PP yielded at the
highest load of 93 N (95% CI 78 to 108), followed byMT (91 N, 95% CI
77 to 106), MC (90, 75 to 104), TA (89, 74 to 104), SH (87, 70 to 104),
FP (78, 61 to 95), CA (77, 62 to 92), and EL (67, 53 to 82). The
fractional dissipated energy was signiﬁcantly different between
joints (P ¼ 0.003, Table II with maximum displacement), with PP
(94%, 95% CI 88 to 101%) having the highest fractional dissipated
energy, followed by SH, EL, FP, TA, CA, MT, and the lowest MC (78%,
95% CI 72 to 85%).Chondrocyte distribution
The distribution of cells was ﬁt to an exponential decay curve to
determine if cell density varied in cartilage between different joints
(Table III, Fig. 2). The exponential decay rate length of cell density
was not statistically different between joints (P ¼ 0.254). Increased
decay rate length was found in the FP joint (560 mm, 95% CI169 to
1290) indicating a more diffuse distribution of cells from surface to
deep zone. Minimal decay rate length was found in the CA joint
(273 mm, 95% CI 48 to 497) indicating a high density of cells at the
surface and a rapid decrease in density of cells with depth. The
goodness of ﬁt for the exponential model was evaluated by the
correlation R2. The best ﬁt was found in the MT joint (R2 ¼ 0.78).
The worst ﬁt was found in the SH joint (R2 ¼ 0.57).w (EL), carpal (CA), metacarpal (MC), proximal interphalangeal (PP), patellofemoral
distance (mm) and fractional dissipated energy as percentage is reported with 95%
een joints and is reported with non-shaded boxes having P  0.05, light gray boxes
MC CA EL SH
1.46) 0.44 (0.37e0.51) 0.29 (0.27e0.30) 0.57 (0.54e0.59) 0.88 (0.73e1.04)
78 (72,85) 82 (76,89) 87 (81,94) 93 (86,101)
<0.001 0.004 0.069 0.811
0.572 0.604 0.076 0.004
0.198 0.819 0.278 0.019
0.037 0.233 0.993 0.169
0.284 0.024 0.001
0.193 0.012
0.142
rvewas ﬁt to the data points of cell density as a function of depth. A smaller value has
er (SH), elbow (EL), carpal (CA), metacarpal (MC), proximal interphalangeal (PP),
lengths were not statistically different between joints (P ¼ 0.289, n ¼ 4 horses).
MC PP FP TA MT
345 420 560 236 266
520 285 169 134 151
1210 1124 1290 338 381
0.71 0.67 0.61 0.77 0.78
0.03 0.03 0.14 0.08 0.60
1.39 1.36 1.37 1.46 0.96
Fig. 2. Exponential decay rate length of cell density in cartilage. The thickest cartilage
with the longest decay rate length was found in the patellofemoral joint (FP, mean ¼
560 mm, 95% CI 169 to 1290 mm) and is shown with the thinnest cartilage with the
shortest decay rate length that was found in the carpal joint (CA, mean ¼ 273 mm, 95%
CI 48 to 497 mm). Lengths of exponential decay rate between joints were not statis-
tically different from each other (P ¼ 0.289, n ¼ 4).
Table IV
Distribution of superﬁcial zone chondrocytes. Peak superﬁcial zone cell density was
signiﬁcantly higher in the metacarpus (MC) than the patellofemoral (FP, P < 0.001),
proximal interphalangeal (PP, P ¼ 0.001), shoulder (SH, P ¼ 0.002), elbow (EL,
P ¼ 0.002), carpal (CA, P ¼ 0.005), and tarsal (TA, P ¼ 0.032) joints. Density in the
metatarsus (MT) was signiﬁcantly higher than FP (P ¼ 0.002), PP (P ¼ 0.003), SH
(P ¼ 0.007), EL (P ¼ 0.007), and CA (P ¼ 0.015).*indicates P < 0.05 difference from
MC; indicates P < 0.05 difference from MT. CI ¼ conﬁdence interval; n ¼ 4 horses.
Quantities reported as 103 cells mm2
SH EL CA MC PP FP TA MT
Peak density 0.78* 0.86* 0.96* 1.97 0.67* 0.67* 1.23* 1.80
95% CI: lower 0.30 0.41 0.26 1.37 0.15 0.06 0.27 0.62
95% CI: upper 1.27 1.31 1.67 2.57 1.19 1.24 2.20 3.01
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between joints, range: 0.20e2.54 103 cells/mm2 (Fig. 3, Table IV).
MC had the highest mean density and was signiﬁcantly higher than
FPwith the lowest density (P< 0.001), PP (P¼ 0.001), SH (P¼ 0.002),
EL (P¼ 0.002), CA (P¼ 0.005), and TA (P¼ 0.032).MT had the second
highest density and was signiﬁcantly higher than FP (P ¼ 0.002), PP
(P ¼ 0.003), SH (P ¼ 0.007), EL (P ¼ 0.007), and CA (P ¼ 0.015). The
depth at which the maximal cell density occurred was not statisti-
cally different between joints (P ¼ 0.306, Fig. 3). Peak density
occurred at 0e50 mm in 10% of samples, 50e100 mm in 60%,
100e150 mm in 27%, and 150e200 mm in 3% of samples. The overall
mean depth of peak density was 87 mm (95% CI 75 to 99 mm).Cell death after injury
Cell death was compared between control and injured samples
to determine if therewas a difference in susceptibility to death afterFig. 3. Distribution of superﬁcial zone chondrocyte proﬁles. Peak superﬁcial zone cell
density was signiﬁcantly higher in the metacarpus (MC) than the patellofemoral (FP,
P ¼ 0.001), proximal interphalangeal (PP, P ¼ 0.001), shoulder (SH, P ¼ 0.003), elbow
(EL, P ¼ 0.002), carpal (CA, P ¼ 0.005), and tarsal (TA, P ¼ 0.033) joints. Density in the
metatarsus (MT) was signiﬁcantly higher than FP (P ¼ 0.002), PP (P ¼ 0.004), SH
(P ¼ 0.008), EL (P ¼ 0.007), and CA (P ¼ 0.016).injury between joints. Overall injured samples had signiﬁcantly
higher cell death (21.0%, 95% CI 17.4 to 24.6%) than non-injured
samples (6.8%, 95% CI 3.6 to 10.1%, P < 0.001). However, cell death
was not signiﬁcantly different between joints within controls
(P ¼ 0.567) or within injured joints (P ¼ 0.995). MC had the highest
relative increase in cell death after injury (16.7% difference, 95% CI
1.5 to 32.6% difference), followed by PP (16.7,2.4 to 35.8), TA (14.8,
1.3 to 28.3), MT (14.7, 0.9 to 30.3), FP (13.3, 2.3 to 28.8), EL
(12.3,1.2 to 25.8), TA (12.1,1.4 to 25.6), and SH (8.9,6.6 to 24.5).
Gene expression
Gene expression in control, uninjured samples was evaluated to
determine if there were differences in chondrocyte expression
between joints. Expression levels of AGG P ¼ 0.039, CD-RAP
(P < 0.001), COL2A1 (P ¼ 0.001), HSP90 (P ¼ 0.024), SAA (P ¼ 0.039),
and MMP-1 (P ¼ 0.001) were signiﬁcantly different between joints
(CD-RAP Table V; all others Supplemental Table). No signiﬁcant
differences in baseline gene expression were found in MMP-13
(P ¼ 0.138).
AGG expression in PP was 7.0 higher than in FP (P ¼ 0.005),
8.3 higher than CA (P ¼ 0.004), 4.9 higher than EL (P ¼ 0.008),
and 2.4 higher than SH (P ¼ 0.045). AGG expressionwas also 5.3
and 6.3 higher in PP than FP (P ¼ 0.033) and CA (P ¼ 0.028),
respectively.
CD-RAP expression in PPwas 2.0 higher than inMT (P¼ 0.016),
16.3 higher than in FP (P < 0.001), 6.6 higher than in CA
(P< 0.001), 4.3 higher than in EL (P¼ 0.001), and 5.9 higher than
in SH (P < 0.001). CD-RAP expression in TA was 1.8 higher than in
MT (P ¼ 0.050), 14.6 higher than in FP (P < 0.001), 5.9 higher
than in CA (P¼ 0.001), 3.8 higher than in EL (P ¼ 0.002), and 5.3
higher than in SH (P ¼ 0.001). CD-RAP expression in CA was 11.5
higher than FP (P ¼ 0.003), 4.6 higher than TA (P ¼ 0.009), 3.0
higher than EL (P ¼ 0.023), and 4.2 higher than SH (P ¼ 0.003).
COL2A1 expression in PPwas 3.5 higher than inMT (P < 0.001),
2.5 higher than in TA (P ¼ 0.002), 13.9 higher than in FP
(P < 0.001), 2.8 higher than in MC (P¼ 0.001), 5.8 higher than in
CA (P < 0.001), 5.8 higher than in EL (P < 0.001), and 9.6 higher
than in SH (P < 0.001).
HSP90 expression in PP was 2.2 higher than in MT (P ¼ 0.030),
5.5 higher than in FP (P ¼ 0.002), 3.2 higher than in MC
(P¼ 0.008), 3.8 higher than in CA (P ¼ 0.005), 6.0 higher than in
EL (P ¼ 0.002), and 6.1 higher than in SH (P ¼ 0.002).
MMP-1 expression in TAwas 4.4 higher than in PP, 4.4 higher
than in MT, 4.7 higher than in FP, 2.8 higher than in MC, 2.7
higher than in CA, 4.5 higher than in EL, and 4.1 higher than in
SH (all P < 0.001).
SAA expression in TAwas 13.4 higher than PP (P¼ 0.003), 2.6
higher than MC (P ¼ 0.034), 4.5 higher than CA (P ¼ 0.009), 3.3
higher than EL (P¼ 0.018), and 4.4 higher than SH (P¼ 0.018). SAA
expression in FP was 10.3 higher than in PP (P ¼ 0.018).
Table V
Baseline mRNA expression and change in mRNA expression after injury was signiﬁcantly different between joints (P < 0.001 and P ¼ 0.028, respectively). Cp ratio values
increasewith increased gene expression;mRNA expression after injury is shown as percent difference between control and injured. Amixedmodel ANOVAwith joint as a ﬁxed
factor and the horse as a random factor was used to compare gene expression between shoulder (SH), elbow (EL), carpal (CA), metacarpal (MC), proximal interphalangeal (PP),
patellofemoral (FP), tarsal (TA), and metatarsal (MT) joints. The mean Cp value with 95% conﬁdence interval (95CI) is reported. An LSD post-hoc test was used to determine
differences between joints and is reported with non-shaded boxes having P  0.05, light gray boxes having 0.001  P < 0.05, and dark gray boxes having P < 0.001
CD-RAP: control PP MT TA FP MC CA EL SH
Cp 344 (243,444) 171 (70,272) 309 (209,410) 21 (80,122) 243 (143,344) 53 (48,153) 81 (20,182) 58 (43,159)
PP 0.016 0.605 <0.001 0.143 <0.001 0.001 <0.001
MT 0.05 0.035 0.289 0.089 0.189 0.103
TA <0.001 0.331 0.001 0.002 0.001
FP 0.003 0.641 0.378 0.585
MC 0.009 0.023 0.011
CA 0.673 0.936
EL 0.733
CD-RAP: injury PP MT TA FP MC CA EL SH
% difference 34 (117,49) 18 (65,102) 30 (54,113) 147 (64,231) 57 (140,26) 101 (5,197) 25 (58,108) 41 (125,42)
PP 0.368 0.275 0.004 0.689 0.039 0.312 0.898
MT 0.844 0.033 0.198 0.194 0.910 0.305
TA 0.050 0.141 0.260 0.933 0.225
FP 0.002 0.457 0.042 0.003
MC 0.017 0.164 0.785
CA 0.673 0.936
EL 0.733
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uate differences in the gene response of chondrocytes between
joints. After injury, therewas a signiﬁcant difference between joints
in gene expression of CD-RAP (P ¼ 0.028, Table V). No other sig-
niﬁcant differences were found (18S P ¼ 0.582, AGG P ¼ 0.589,
COL2A1 P ¼ 0.063, HSP90 ¼ 0.328, MMP-1 P ¼ 0.761, MMP-13
P ¼ 0.191, SAA P ¼ 0.248).
Discussion
Comparison of baseline characteristics in normal cartilage and
response to injury in eight different joints was performed to better
understand the response of cartilage to traumatic compressive
injury. Between joints, differences were found in fractional dissi-
pated energy, superﬁcial zone cell density, and gene expression.
These results suggest joints may have varying susceptibilities to the
development of PTOA.
Explants were loaded with a peak stress previously shown to
cause cell death24, with a mean peak stress rate shown to cause
surface ﬁssures and cell death29. This loading conditionwas used to
create an injury model that results in increased but not 100% cell
death. Similar loading conditions have been used as injury models
to understand PTOA.While different joints will experience different
loading in vivo, a similar loading condition that represents about
2e3-fold the normal physiologic loading in the equine forelimb30
was used in the present study for all joints to minimize vari-
ability within the model. Using the same loading condition for all
joints may not be reﬂective of joint-speciﬁc in vivo conditions and
would have also led to the resulting strains of explants being
different between joint. However, without established joint-
speciﬁc injury models, this load-control model helped to mini-
mize other varying factors. The peak stress at which samples yiel-
ded was not signiﬁcantly different. The relative quantity of energy
that was dissipated from loading was signiﬁcantly different be-
tween joints. This fractional dissipated energy was highest in PP
followed by SH, EL, and FP. Joints with lower fractional dissipated
energy were TA, CA, MT, and the lowest MC. A negative correlation
between shoulder and knee cartilage thickness and stiffness
determined by equilibrium modulus has been previously reported
in beagles12, suggesting that joints with different cartilage thick-
ness may dissipate energy differently during compressive loading.Similarly, FP was found to have higher dissipated energy and has
been shown to have thicker cartilage than CA or MC31. However,
thickness of cartilage is unrelated to normal standing stress14. This
suggests that although a single joint in a limbwill see similar forces
in vivo, cartilages will have different thickness between joints and
different abilities to absorb compressive loading. While this infor-
mation may not directly help minimize the risk for developing OA
in thicker cartilages, it conveys a need to treat and study OA
differently between these very different types of cartilage.
Cell density was quantiﬁed to determine had differences in
exponential decay rate length of cell density from superﬁcial to
deep zones between joints. The cell density decay rate was not
statistically different between joints. This suggests that the distri-
bution of cells within cartilage from articular surface to the deep
zone was similar between joints, with most cells found in the su-
perﬁcial zone. Full-depth cellular distribution may not be a key
factor in susceptibility to PTOA development. However, cell density
within the superﬁcial zone was signiﬁcantly different between
joints. Cell density in the superﬁcial zonewas higher in both theMC
and MT than in other joints. The importance of the superﬁcial zone
in absorbing energy from trauma has become more apparent in
recent research13. For example, thickness of the superﬁcial zone has
been associated with mechanical properties of cartilage, including
having a positive correlation with the isotropic indentation
modulus12. Furthermore, differences in the response to cytokine
and mechanical stimuli8,9 and equilibriummodulus and stiffness of
cartilage10,21 may result from differences in concentration of su-
perﬁcial zone cells. This suggests that if the superﬁcial zone is
different between joints, one joint may be able to absorb energy
without mechanical damage while another joint under the same
conditions may experience matrix damage.
Cell death was increased with the chosen loading condition,
which is similar to previous studies24,25, allowing for comparison of
deathandgeneexpressionafter injury. Yet, no signiﬁcantdifferences
in cell death between joints were found, suggesting that although
cell death could be associatedwith development of disease, it might
not be correlated with varying prevalence of PTOA between joints.
Gene expression was quantiﬁed to investigate differences in
cellular activity between joints. AGG, CD-RAP, COL2A1, MMP-1, and
SAA had signiﬁcantly different mRNA expression between joints in
control cartilage. Expression of CD-RAP is associated with increased
K.D. Novakofski et al. / Osteoarthritis and Cartilage 23 (2015) 1130e11371136cell proliferation and is diminished in severe OA32. CD-RAP was
examined because its expression can change during very early
response to stimuli (<48 h) and is down-regulated by IL-1b and
TGF-b33. Synthesis of collagen type II is important for maintaining
cartilage matrix34. Aggrecan is a key component of the matrix. SAA
andMMP-1 are indicators of cellular catabolism. Overall, FP tended
to have lower anabolic gene expression, including AGG, CD-RAP, and
COL2A1, and higher expression of SAA. High SAA and MMP-1
expression were similarly found in TA. PP tended to have the
opposite trend. After injury, CD-RAP expression was signiﬁcantly
increased in FP, indicating that FP is a faster responder to injury
than other joints. However, this immediate response cannot be
extrapolated to long term response or long term healing. Interest-
ingly, superﬁcial zone cell density was less in FP and TA than MC.
This could indicate that joints such as MCs with high superﬁcial
zone cellular density respond differently than cartilage in low su-
perﬁcial zone cellular density joints. However, additional factors
not examined in this paper, such as in vivo loading conditions
during every day activities, may contribute to these gene expres-
sion differences.
The random effect of individual animal was used in the statis-
tical model. The animals were not bred for research and did not
have controlled activity, as would be similarly found with people.
While there was individual variability present, one individual was
not consistently more resilient to injury than another. Images from
injured samples weremanually counted due to the high irregularity
of collagen and ﬂuorescence signals. Decreased signal emission in
the impacted sitemade identiﬁcation of cells, dead or alive, difﬁcult
and may have lead to a diminished area of damaged tissue being
counted, creating a potential lower reported cell death. Yet, sig-
niﬁcance was found between control and injured groups despite
this potential limitation.
Overall, differences were found between joints in fractional
dissipated energy, superﬁcial zone cell density, and gene expres-
sion. Superﬁcial zone chondrocytes weremost dense inMTandMC,
suggesting cells in this zone may be different between joints.
Baseline CD-RAP was lower in FP, yet after injury, CD-RAP expres-
sion increased in FP. These differences between joints suggest
ﬁndings from a single joint cannot be extrapolated to other joints.
Baseline characteristics of chondrocytes in different joints may
have an effect on how cartilage responds differently to injury be-
tween joints. This may result in different pathologies of PTOA be-
tween joints and subsequently in joint-speciﬁc future targets for
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